• August 9, 2022

    Rome Health implements tracking software to assist in the early detection of lung cancer  

    Lung screening criteriaRome Health now has advanced lung cancer screening tracking software to help providers ensure that eligible patients receive critical screenings and follow up to assist in the early detection of lung cancer.

    More people are now eligible for low-dose lung CT screening, under the expanded guidelines from the US Preventative Services Task Force. Speak with your provider today to get your screening scheduled.

    Rome Health is a leading provider of screening services and personalized medicine. It has further demonstrated its commitment to patients in the Central New York region by adopting Volpara® Lung™ software, a comprehensive lung health tracking and management system.

    “Lung cancer screening is essential care, especially for high-risk patients,” said Dr. John Restivo, chairman of Medical Imaging at Rome Health. “The newly expanded guidelines include a broader population than ever before, and we need to spread the message that lung cancer extends beyond smokers and previous smokers: there are many other people at risk for lung cancer. Volpara Lung software makes it easy for us to track screened patients, ensuring they receive critical follow-ups, and to notify providers of current recommended guidelines for at risk patients.”

    For both smokers and non-smokers, it is essential to detect lung cancer early, when it is still treatable. The importance of early detection helped inform the recent decision by the United States Preventive Services Task Force (USPSTF) to broaden the patient population eligible to receive low-dose lung CT screening.
    Now, those who are between 50 and 80 years of age, who currently smoke or have quit smoking in the past 15 years, and who have a 20 pack-year smoking history are eligible for this potentially life-saving screening.

    Lung cancer is the leading cause of cancer-related deaths for both men and women in the United States, with over 350 deaths per day predicted in 2022. Though it is often considered a smoker’s disease, this is not the full story—in fact, nearly 20 percent of patients who develop lung cancer have never smoked a cigarette.

    Volpara Lung is designed to streamline and enrich lung screening through time-saving processes and automation. Using Volpara Lung as a one-stop solution, healthcare providers can easily submit all necessary data to the American College of Radiology Lung Cancer Screening Registry (ACR LCSR), as well as generate over 40 statistical lung cancer screening reports that provide clear, real-time patient insights.

    Rome Health’s team of committed imaging professionals use their expertise to offer top-quality care. Volpara Lung software will empower them to find lung cancers earlier, and more easily track at-risk individuals.

    “We are excited to elevate the care we offer to our patients, while helping improve efficiency for our imaging staff,” said Sharon Carson, Medical Imaging director at Rome Health. “We want to reduce lung cancer deaths in our community, and Volpara Lung can help us provide early detection for more people as we expand our screening workflows.”